Sun Pharma
Search results
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2] . Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed...
Find company research, competitor information, contact details & financial data for DR REDDY'S LABORATORIES LIMITED of Bengaluru, Karnataka. Get the latest business insights from Dun & Bradstreet.
Find company research, competitor information, contact details & financial data for DR.REDDY'S LABORATORIES LIMITED of Hyderabad, Telangana. Get the latest business insights from Dun & Bradstreet.
Dr. Reddy’s Laboratories. 2,612 followers. 10mo. Just finished "Leading with Innovation" by Anil Gupta, and Haiyan Wang! Check it out: https://lnkd.in/dPk5yk-B #innovationmanagement. Arpit...
5 hours ago · Stay up-to-date with the Dr. Reddy's Laboratories Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a prominent stock. Explore the latest information on Dr. Reddy's Laboratories, including: Last traded price 6255.45, Market capitalization: 104026.2, Volume: 1250, Price-to-earnings ratio 18.65, Earnings per share 334.37. Our liveblog provides a comprehensive overview of Dr. Reddy's Laboratories by integrating fundamental and technical indicators. Stay ...
We accelerate access to affordable and innovative medicines because Good Health Can’t Wait. | Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a...
1 day ago · The acquisition being made by Dr. Reddy’s Laboratories SA is on an upfront cash consideration of GBP 458 million and additional performance-based contingent cash payments of up to GBP 42 million ...
Dr. Reddy’s Laboratories commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
